Vatti Lohith, Fitzgerald-Butt Sara M, McBride Kim L
The Heart Center, Nationwide Children's Hospital, Columbus, Ohio.
Center for Cardiovascular Research, Research Institute, Nationwide Children's Hospital, Columbus, Ohio.
Am J Med Genet A. 2017 Nov;173(11):2995-3002. doi: 10.1002/ajmg.a.38489. Epub 2017 Sep 21.
Marfan syndrome is a multisystem disease with cardiovascular, ophthalmologic, and skeletal features. Diagnosis is made clinically with emphasis on presence of aortic root dilation and ectopia lentis (EL). Most individuals meeting these criteria have a pathogenic variant in FBN1, usually unique or observed rarely. Individuals with EL alone may also have FBN1 pathogenic variants, and the risk for aortic disease is not well known. We identified a unique cohort of 31 individuals (mean age 29, range 2-78) from nine families ascertained by a proband with EL alone, who had the same FBN1 p.R650C variant. Comparison was made to individuals with Marfan syndrome (n = 103 from 97 families) at our institution. Those with the p.R650C variant had few skeletal features of Marfan syndrome. Age of onset of EL was later compared to others with cysteine variant changes. Aortic root dilation occurred in 4/16 (25%) of the p.R650C group versus 71/83 (86%) in the comparator group (p < 0.001) and dissection or replacement in 1/31 (3%) versus 20/103 (19%; p < 0.04). Aortic root Z scores were much lower in the p.R650C (0.34 ± 1.70) versus the comparator (2.99 ± 2.54; p < 0.0002). Kaplan-Meier failure curves for aortic root dilation demonstrated later age of onset and differed significantly for incidence rate ratio (comparator vs. p.R650C = 5.35, CI 1.84-21.17; p = 0.0001). Individuals with p.R650C predominantly have EL, but do have risk for aortic dilation at ages later than typical for Marfan syndrome in general and for cysteine changes specifically. Surveillance for aortic dilation is required but may occur less frequently.
马凡综合征是一种具有心血管、眼科和骨骼特征的多系统疾病。临床诊断主要依据主动脉根部扩张和晶状体异位(EL)的存在。大多数符合这些标准的个体在FBN1基因中有致病性变异,通常是独特的或很少见的。仅患有EL的个体也可能有FBN1致病性变异,而主动脉疾病的风险尚不清楚。我们从9个家庭中确定了一组独特的31名个体(平均年龄29岁,范围2 - 78岁),这些家庭由仅患有EL的先证者确定,他们具有相同的FBN1 p.R650C变异。与我们机构中患有马凡综合征的个体(来自97个家庭的103名)进行了比较。携带p.R650C变异的个体几乎没有马凡综合征的骨骼特征。与其他有半胱氨酸变异改变的个体相比,EL的发病年龄较晚。p.R650C组中16人中有4人(25%)发生主动脉根部扩张,而对照组中83人中有71人(86%)发生(p < 0.001);p.R650C组中31人中有1人(3%)进行了主动脉夹层修复或置换,而对照组中103人中有20人(19%;p < 0.04)。p.R650C组的主动脉根部Z评分(0.34 ± 1.70)远低于对照组(2.99 ± 2.54;p < 0.0002)。主动脉根部扩张的Kaplan-Meier失败曲线显示发病年龄较晚,发病率比有显著差异(对照组与p.R650C组 = 5.35,CI 1.84 - 21.17;p = 0.0001)。携带p.R650C变异的个体主要患有EL,但确实在比一般马凡综合征典型发病年龄更晚、比特定半胱氨酸变异改变发病年龄更晚的时候有主动脉扩张的风险。需要对主动脉扩张进行监测,但监测频率可能较低。